These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 141355)

  • 21. Etanercept in combination with sulfasalazine, hydroxychloroquine, or gold in the treatment of rheumatoid arthritis.
    O'Dell JR; Petersen K; Leff R; Palmer W; Schned E; Blakely K; Haire C; Fernandez A
    J Rheumatol; 2006 Feb; 33(2):213-8. PubMed ID: 16358366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Gold salts and rheumatoid polyarthritis. Preliminary results of a retrospective survey].
    Boasson M; Bernat M; Renier JC
    Rhumatologie; 1972 Apr; 24(4):115-21. PubMed ID: 5077712
    [No Abstract]   [Full Text] [Related]  

  • 23. Disease-modifying agents and experimental treatments of rheumatoid arthritis.
    Weinblatt ME; Maier AL
    Clin Orthop Relat Res; 1991 Apr; (265):103-15. PubMed ID: 2009648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of evolutive chronic polyarthritis with chrysotherapy. Reports. Conclusions. Summaries].
    Rev Rhum Mal Osteoartic; 1971 Nov; 38(11):669-79. PubMed ID: 5004879
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of chrysanol in rheumatoid arthritis].
    Urbaniuk KG; Mazurets AF; Kobranova GP; Zarapin VP
    Vrach Delo; 1983 Jan; (1):37-40. PubMed ID: 6868495
    [No Abstract]   [Full Text] [Related]  

  • 26. High dose, low frequency parenteral gold administration.
    Norton WL; Donnelly RJ
    J Rheumatol; 1983 Jun; 10(3):454-8. PubMed ID: 6411920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The prevention of chrysotherapy complications in patients with rheumatoid arthritis].
    Berezhnitskiĭ MN; Ornat SIa; Aleksandruk DP
    Vrach Delo; 1989 Apr; (4):55-7. PubMed ID: 2756689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral pulsed dexamethasone therapy in early rheumatoid arthritis: a pilot study.
    Kroot EJ; Huisman AM; Van Zeben J; Wouters JM; Van Paassen HC
    Ann N Y Acad Sci; 2006 Jun; 1069():300-6. PubMed ID: 16855157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Gold treatment of rheumatoid arthritis].
    Wagner H; Wirth W
    Z Rheumatol; 1978; 37(1-2):4-11. PubMed ID: 415451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gold treatment of rheumatoid arthritis decreases synovial expression of the endothelial leukocyte adhesion receptor ELAM-1.
    Corkill MM; Kirkham BW; Haskard DO; Barbatis C; Gibson T; Panayi GS
    J Rheumatol; 1991 Oct; 18(10):1453-60. PubMed ID: 1722512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A reevaluation of aspirin therapy in rheumatoid arthritis.
    Fries JF; Ramey DR; Singh G; Morfeld D; Bloch DA; Raynauld JP
    Arch Intern Med; 1993 Nov; 153(21):2465-71. PubMed ID: 8215751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chrysotherapy: a synoptic review.
    Eisler R
    Inflamm Res; 2003 Dec; 52(12):487-501. PubMed ID: 14991077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis.
    Singh G; Fries JF; Williams CA; Zatarain E; Spitz P; Bloch DA
    J Rheumatol; 1991 Feb; 18(2):188-94. PubMed ID: 1673721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonsteroidal anti-inflammatory agents in arthritis.
    Ridolfo AS
    Am Fam Physician; 1978 Feb; 17(2):131-8. PubMed ID: 622939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meta-analysis of injectable gold in rheumatoid arthritis.
    Clark P; Tugwell P; Bennett K; Bombardier C
    J Rheumatol; 1989 Apr; 16(4):442-7. PubMed ID: 2664167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors influencing length of time taking methotrexate in rheumatoid arthritis.
    Ortendahl M; Schettler JD; Fries JF
    J Rheumatol; 2000 May; 27(5):1139-47. PubMed ID: 10813279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Concentration of gold in macrophages of the bone marrow in rheumatic diseases subjected to chrysotherapy].
    Galle P; Villiaumey J
    Rev Rhum Mal Osteoartic; 1982 Mar; 49(4):273-9. PubMed ID: 7089467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparison of treatment outcome in patients with rheumatoid arthritis treated with TFX- Polfa or gold salts after a one year follow up].
    Lewandowicz J
    Pol Tyg Lek; 1992 Dec 7-14; 47(49-50):1102-4. PubMed ID: 1305735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group.
    Kalden JR; Scott DL; Smolen JS; Schattenkirchner M; Rozman B; Williams BD; Kvien TK; Jones P; Williams RB; Oed C; Rosenburg R;
    J Rheumatol; 2001 Sep; 28(9):1983-91. PubMed ID: 11550964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of combined drug treatment using gold preparations on indices of lipid peroxidation in patients with rheumatoid arthritis].
    Makarchuk OS
    Vrach Delo; 1990 Mar; (3):70-2. PubMed ID: 1973321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.